Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Effects of Oral Collagen Drinks on Human Skin

8 juillet 2026 mis à jour par: TCI Co., Ltd.
The objective of this study is to evaluate the effect of oral collagen drink and MAXI collagen drink on human skin condition improvement.

Aperçu de l'étude

Statut

Complété

Les conditions

Intervention / Traitement

Description détaillée

This study is a single-center, double-blinded, parallel human trial designed to evaluate the skin beauty effect of oral collagen drink and MAXI collagen drink.

Healthy adult participants aged 18-60 years will be enrolled. Participants will be informed to consume test samples daily for 4 consecutive weeks. Skin measurement and self-assessment questionnaires will be conducted at baseline (before intake), after 1 week, and 4 weeks of consumption.

Type d'étude

Interventionnel

Inscription (Réel)

105

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

  • Chine
      • Beijing, Chine
        • Beijing Ewish Testing Technology Co.,ltd.

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte

Accepte les volontaires sains

Oui

La description

Inclusion Criteria:

  • Healthy Chinese subjects aged 18 to 60 years, both male and female.
  • Wrinkle Severity: Crow's feet graded 2-4; under-eye fine lines graded 2-5; nasolabial folds graded 1-3.
  • Presence of facial skin laxity and sagging.
  • Ability to undergo skin examinations and pre-treatment in the designated test areas.
  • Ability to understand the trial process, participate voluntarily, and sign a written Informed Consent Form (ICF).

Exclusion Criteria:

  • Pregnant or lactating women, or those planning to become pregnant in the near future.
  • Highly sensitive constitution, history of allergic diseases, or history of allergies to cosmetics.
  • Presence of skin diseases (e.g., psoriasis, eczema, atopic dermatitis, severe acne) or other chronic systemic diseases.
  • Skin conditions in the test area such as birthmarks, hyperpigmentation, inflammation, scars, nevi (moles), or hypertrichosis (excessive hair).
  • Use of anti-inflammatory drugs (e.g., oral or topical corticosteroids) within the past month.
  • Use of cosmetics or other products with similar efficacy within the past 2 weeks.
  • Participation in other human clinical trials for cosmetics within the past month.
  • Any other conditions deemed unsuitable for participation based on clinical assessment.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Double

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: Collagen Drink
oral intake 5 g collagen daily
Complément alimentaire: Collagen Drink
consume 1 bottle of the test samples daily for 4 consecutive weeks, each bottle containing 5 g Collagen Powder
Expérimental: MAXI Collagen Drink
oral intake 15 mL MAXI collagen daily (equivalent to 5 g of deep hydrolyzed collagen net weight)
Complément alimentaire: MAXI Collagen Drink
consume 1 bottle of the test samples daily for 4 consecutive weeks, each bottle containing 15 mL MAXI Collagen Liquid (equivalent to 5 g of deep hydrolyzed collagen net weight)
Expérimental: MAXI Collagen Drink_High dose
oral intake 30 mL MAXI collagen daily (equivalent to 10 g of deep hydrolyzed collagen net weight)
Complément alimentaire: MAXI Collagen Drink_High dose
consume 1 bottle of the test samples daily for 4 consecutive weeks, each bottle containing 30 mL MAXI Collagen Liquid (equivalent to 10 g of deep hydrolyzed collagen net weight)

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
The change of collagen fiber fluorescence intensity
Délai: Change from Baseline collagen intensity at 4 weeks
SUPERVISION-780 In-Vivo Imaging System (Survface, China) was utilized to evaluate the density and quality of dermal collagen fibers.
Change from Baseline collagen intensity at 4 weeks

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
The change of skin elasticity
Délai: Change from Baseline skin elasticity at 4 weeks
Cutometer® MPA580 (CK, Germany) was utilized to measure the gross elasticity of the skin using suction method.
Change from Baseline skin elasticity at 4 weeks
The change of skin firmness
Délai: Change from Baseline skin firmness at 4 weeks
Cutometer® MPA580 (CK, Germany) was utilized to measure skin firmness and the area under the suction curve.
Change from Baseline skin firmness at 4 weeks
The change of epidermal thickness
Délai: Change from Baseline epidermal thickness at 4 weeks
SUPERVISION-780 In-Vivo Imaging System (Survface, China) was utilized to measure the depth of the epidermal layer using optical imaging.
Change from Baseline epidermal thickness at 4 weeks
The change of cheek skin roughness
Délai: Change from Baseline skin roughness at 4 weeks
AEVA-HE (EOTECH, France) was utilized to measure the arithmetic average roughness (Ra value) of the cheek surface.
Change from Baseline skin roughness at 4 weeks
The change of the Dermal-Epidermal Junction (DEJ) structures
Délai: Change from Baseline DEJ status at 4 weeks
SUPERVISION-780 In-Vivo Imaging System (Survface, China) was utilized to assess the structural integrity and epithelial-connective tissue interface (ECTI) of the DEJ.
Change from Baseline DEJ status at 4 weeks
The change of nasolabial folds volume
Délai: Change from Baseline wrinkle parameters at 4 weeks
AEVA-HE (EOTECH, France) was utilized to quantify the 3D morphological changes of the nasolabial folds volume.
Change from Baseline wrinkle parameters at 4 weeks
The change of nasolabial folds depth
Délai: Change from Baseline wrinkle parameters at 4 weeks
AEVA-HE (EOTECH, France) was utilized to quantify the 3D morphological changes of the nasolabial folds depth.
Change from Baseline wrinkle parameters at 4 weeks
The change of crow's feet volume
Délai: Change from Baseline crow's feet parameters at 4 weeks
AEVA-HE (EOTECH, France) was utilized to measure the severity of crow's feet volume.
Change from Baseline crow's feet parameters at 4 weeks
The change of crow's feet depth
Délai: Change from Baseline crow's feet parameters at 4 weeks
AEVA-HE (EOTECH, France) was utilized to measure the severity of crow's feet depth.
Change from Baseline crow's feet parameters at 4 weeks
The change of the volume of fine lines under the eyes
Délai: Change from Baseline fine lines at 4 weeks
AEVA-HE (EOTECH, France) was utilized to assess the volume of fine lines under the eyes.
Change from Baseline fine lines at 4 weeks
The change of the mean depth of fine lines under the eyes
Délai: Change from Baseline fine lines at 4 weeks
AEVA-HE (EOTECH, France) was utilized to assess the mean depth of fine lines under the eyes.
Change from Baseline fine lines at 4 weeks
The change of cheek (malar) volume
Délai: Change from Baseline cheek volume at 4 weeks
AEVA-HE (EOTECH, France) was utilized to measure the 3D volume of the cheek area for lifting effects.
Change from Baseline cheek volume at 4 weeks
The change of jawline length
Délai: Change from Baseline jawline parameters at 4 weeks
AEVA-HE (EOTECH, France) was utilized to measure the linear length and contour of the jawline.
Change from Baseline jawline parameters at 4 weeks
The change of skin pores counts
Délai: Change from Baseline pore parameters at 4 weeks
AEVA-HE (EOTECH, France) was utilized to perform 3D imaging and quantification of skin pores counts.
Change from Baseline pore parameters at 4 weeks
The change of skin pores volume
Délai: Change from Baseline pore parameters at 4 weeks
AEVA-HE (EOTECH, France) was utilized to perform 3D imaging and quantification of skin pores volume.
Change from Baseline pore parameters at 4 weeks
The change of skin hydration
Délai: Change from Baseline skin hydration at 4 weeks
Corneometer® CM825 (CK, Germany) was utilized to measure skin surface hydration. Units: arbitrary Corneometer® units 0-120.
Change from Baseline skin hydration at 4 weeks
The change of transepidermal water loss (TEWL)
Délai: Change from Baseline TEWL at 4 weeks
Tewameter® TM300 (CK, Germany) was utilized to measure the evaporation rate of water from the skin. Units: g/h/m^2.
Change from Baseline TEWL at 4 weeks

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
The change of skin brightness (L*)
Délai: Change from Baseline skin brightness (L*) at 4 weeks
Skin-Colorimeter CL400 (CK, Germany) was utilized to measure skin brightness (L*).
Change from Baseline skin brightness (L*) at 4 weeks
The change of skin individual typology angle (ITA)
Délai: Change from Baseline skin ITA at 4 weeks
Skin-Colorimeter CL400 (CK, Germany) was utilized to measure skin individual typology angle (ITA).
Change from Baseline skin ITA at 4 weeks
The change of skin color parameters
Délai: Change from Baseline skin redness (a*) at 4 weeks
Skin-Colorimeter CL400 (CK, Germany) was utilized to measure skin redness (a*).
Change from Baseline skin redness (a*) at 4 weeks
The change of skin color parameters
Délai: Change from Baseline skin yellow tone (b*) at 4 weeks
Skin-Colorimeter CL400 (CK, Germany) was utilized to measure skin yellow tone (b*).
Change from Baseline skin yellow tone (b*) at 4 weeks

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

TCI Co., Ltd.

Les enquêteurs

  • Chercheur principal: YAO PAN, Beijing Ewish Testing Technology Co.,ltd.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

12 mai 2026

Achèvement primaire (Réel)

15 juin 2026

Achèvement de l'étude (Réel)

30 juin 2026

Dates d'inscription aux études

Première soumission

8 mai 2026

Première soumission répondant aux critères de contrôle qualité

18 mai 2026

Première publication (Réel)

26 mai 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

10 juillet 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

8 juillet 2026

Dernière vérification

1 juillet 2026

Plus d'information

Termes liés à cette étude

Mots clés

Termes MeSH pertinents supplémentaires

Autres numéros d'identification d'étude

  • SECCR2025-254

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner